74
Views
2
CrossRef citations to date
0
Altmetric
Research Article

UNBS5162 as a novel naphthalimide holds efficacy in human gastric carcinoma cell behaviors mediated by AKT/ERK signaling pathway

, , &
Pages 1306-1312 | Received 03 Jan 2019, Accepted 11 Apr 2019, Published online: 24 May 2019

References

  • Li D, Zhang B, Hu C. Oxaliplatin inhibits proliferation and migration of human hepatocellular carcinoma cells via GAS7C and the N-WASP/FAK/F-actin pathway. Acta Biochim Biophys Sin. 2017;49:1–7.
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
  • Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4:540–550.
  • Zhang J, Shi Z, Huang J, et al. CSTB downregulation promotes cell proliferation and migration and suppresses apoptosis in gastric cancer SGC-7901 cell line. Oncol Res. 2016;24:487–494.
  • Ma Z, Wang W, Jin G, et al. Effect of statins on gastric cancer incidence: a meta-analysis of case control studies. J Cancer Res Ther. 2014;10:859–865.
  • Xu C, Xie J, Liang N, et al. Concurrent involved-field radiotherapy and XELOX in gastric cancer patients with postoperative oligometastatic recurrence. J Can Res Ther. 2014;10: 267–271.
  • Tandon R, Luxami V, Kaur H, et al. 1,8-Naphthalimide: a potent DNA intercalator and target for cancer therapy. Chem Rec. 2017;17:956–993.
  • Tian ZY, Xie SQ, Du YW, et al. Synthesis, cytotoxicity and apoptosis of naphthalimide polyamine conjugates as antitumor agents. Eur J Med Chem. 2009;44:393–399.
  • Xie SQ, Li Q, Zhang YH, et al. NPC-16, a novel naphthalimide-polyamine conjugate, induced apoptosis and autophagy in human hepatoma HepG2 cells and Bel-7402 cells. Apoptosis. 2011;16:27–34.
  • Liu C, Xing J, Gao Y. UNBS5162 inhibits the proliferation of human A549 non-small-cell lung cancer cells by promoting apoptosis. Thorac Cancer. 2018;9:105–111.
  • Wang B, Shen J, Wang J. UNBS5162 inhibits proliferation of human retinoblastoma cells by promoting cell apoptosis. OTT. 2017;10:5303–5309.
  • Zhu X, Bai Q, Lu Y, et al. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer. Int J Oncol. 2016;48:2321–2329.
  • Mijatovic T, Mahieu T, Bruyère C, et al. UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. Neoplasia. 2008;10:573–586.
  • Jiang X, Zhu X, Huang W, et al. Garlic-derived organosulfur compound exerts antitumor efficacy via activation of MAPK pathway and modulation of cytokines in SGC-7901 tumor-bearing mice. Int Immunopharmacol. 2017;48:135–145.
  • Li D, Wei X, Ma M, et al. FFJ-3 inhibits PKM2 protein expression via the PI3K/Akt signaling pathway and activates the mitochondrial apoptosis signaling pathway in human cancer cells. Oncol Lett. 2017;13:2607–2614.
  • Liu L, Miao L, Liu Y, et al. S100A11 regulates renal carcinoma cell proliferation, invasion, and migration via the EGFR/Akt signaling pathway and E-cadherin. Tumour Biol. 2017;39:1–8.
  • Zhao E, Tang C, Jiang X, et al. Inhibition of cell proliferation and induction of autophagy by KDM2B/FBXL10 knockdown in gastric cancer cells. Cell Signal. 2017;36:222–229.
  • Jiang C, Tong YL, Zhang D, et al. Sinomenine prevents the development of cardiomyopathy in diabetic rats by inhibiting inflammatory responses and blocking activation of NF-κB. GPB. 2017;36:65–74.
  • Lin X, Song H, Xiao J, et al. Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and apoptosis in human pancreatic cancer SW1900 cells by targeting MTA1. Exp Mol Pathol. 2017;102:522–532.
  • Mahadevan D, Northfelt DW, Chalasani P, et al. Phase I trial of UNBS5162, a novel naphthalimide in patients with advanced solid tumors or lymphoma. Int J Clin Oncol. 2013;18:934–941.
  • Chen Z, Liang X, Zhang H, et al. A new class of naphthalimide-based antitumor agents that inhibit topoisomerase II and induce lysosomal membrane permeabilization and apoptosis. J Med Chem. 2010;53:2589–2600.
  • Hu X, Sui X, Li L, et al. Protocadherin 17 acts as a tumour suppressor inducing tumour cell apoptosis and autophagy, and is frequently methylated in gastric and colorectal cancers. J Pathol. 2013;229:62–73.
  • Chen Y, Fu LL, Wen X, et al. Oncogenic and tumor suppressive roles of microRNAs in apoptosis and autophagy. Apoptosis. 2014;19:1177–1189.
  • Horwacik I, Rokita H. Targeting of tumor-associated gangliosides with antibodies affects signaling pathways and leads to cell death including apoptosis. Apoptosis. 2015;20:679–688.
  • Tian ZY, Xie SQ, Mei ZH, et al. Conjugation of substituted naphthalimides to polyamines as cytotoxic agents targeting the Akt/mTOR signal pathway. Org Biomol Chem. 2009;7:4651–4660.
  • Li M, Li Q, Zhang YH, et al. Antitumor effects and preliminary systemic toxicity of ANISpm in vivo and in vitro. Anticancer Drugs. 2013;24:32–42.
  • Xu WW, Zheng CC, Huang YN, et al. Synephrine hydrochloride suppresses esophageal cancer tumor growth and metastatic potential through inhibition of galectin-3-AKT/ERK signaling. J Agric Food Chem. 2018;66:9248–9258.
  • Wang X, Liu K, Ruan M, et al. Gallic acid inhibits fibroblast growth and migration in keloids through the AKT/ERK signaling pathway. Acta Biochim Biophys Sin. 2018;50:1114–1120.
  • Li Q, Ding C, Meng T, et al. Butyrate suppresses motility of colorectal cancer cells via deactivating Akt/ERK signaling in histone deacetylase dependent manner. J Pharmacol Sci. 2017;135:148–155.
  • Li SL, Chen X, Wu T, et al. Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways. Biomed Pharmacother. 2018;107:841–848.
  • Fan C, Liu J, Tian J, et al. siRNA targeting of the SNCG gene inhibits the growth of gastric carcinoma SGC7901 cells in vitro and in vivo by downregulating the phosphorylation of AKT/ERK. Cytogenet Genome Res. 2018;154:209–216.
  • He D, Zhang S. UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway. Mol Med Rep. 2018;17:549–555.
  • Carrella D. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds. Oncotarget. 2016;7:58743–58758.
  • Ning Dou SY, Ye X, Yang D, et al. Aberrant overexpression of ADAR1 promotes gastric cancer progression by activating mTOR/p70S6K signaling. Oncotarget. 2016;7:86161–86173.
  • Machl A, Wilker EW, Tian H, et al. M2698 is a potent dual-inhibitor of p70S6K and Akt that affects tumor growth in mouse models of cancer and crosses the blood-brain barrier. Am J Cancer Res. 2016;6:806–818.
  • Yin CY, Lin XL, Tian L, et al. Lobaplatin inhibits growth of gastric cancer cells by inducing apoptosis. WJG. 2014;20:17426–17433.
  • Lee HW, Jang KS, Choi HJ, et al. Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy. BMB Rep. 2014;47:697–702.
  • Yuan L, Wei S, Wang J, et al. Isoorientin induces apoptosis and autophagy simultaneously by reactive oxygen species (ROS)-related p53, PI3K/Akt, JNK, and p38 signaling pathways in HepG2 cancer cells. J Agric Food Chem. 2014;62:5390–5400.
  • Zhao R, Chen M, Jiang Z, et al. Platycodin-D induced autophagy in non-small cell lung cancer cells via PI3K/Akt/mTOR and MAPK signaling pathways. J Cancer. 2015;6:623–631.
  • Zhao X, Qi T, Kong C, et al. Photothermal exposure of polydopamine-coated branched Au–Ag nanoparticles induces cell cycle arrest, apoptosis, and autophagy in human bladder cancer cells. IJN. 2018;13:6413–6428.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.